After Waiting Years for Justice, Many Purdue Pharma Opioid Victims are Defeated – by Paperwork

Although nearly 140,000 people submitted claims in 2021, many are discovering too late that they must provide detailed proof that the opioids they or their loved ones took were specifically manufactured by Purdue Pharma. Medical records often do not specify drug manufacturers, and pharmacies, insurers, and healthcare providers are not required to retain records for long periods.

Many claimants initially filed without documentation, believing it was unnecessary, only to be told years later – after records had been destroyed – that proof was essential. The settlement rules were tightened during lengthy legal proceedings, eliminating earlier provisions that would have allowed compensation based on sworn statements alone. As a result, thousands of victims who believe Purdue’s actions contributed to them becoming addicted to opioid drugs are now unable to qualify for compensation.

The situation highlights broader tensions over accountability for America’s opioid epidemic. While Purdue Pharma has admitted misconduct and pleaded guilty to criminal charges related to misleading marketing, its bankruptcy plan limits compensation to harms directly tied to its own products. Critics argue this ignores the company’s role in fueling a wider crisis that extended beyond branded drugs to generics and illegal opioids. Even for successful claimants, payouts are only expected to be modest – typically between $8,000 and $16,000.

To learn more about America’s opioid epidemic, see this article on our website.